Buys
Open market- Shares
- +64,000
- Avg price
- $0.8745
- Total value
- +$55,968
Ramtin Agah - Chief Medical Officer, Director at RenovoRx, Inc.
Issuer-level insider activity
- Role
- Chief Medical Officer, Director
- Issuer ticker
- RNXT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Ramtin Agah in RenovoRx, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +64,000
- Share %
- 100%
- Total value
- +$55,968
Reported holdings for Ramtin Agah in RenovoRx, Inc.
Form 4 holding
Chief Medical Officer, Director
RenovoRx, Inc.
- Security class
- Common Stock
- Shares / value
- 798,460
- Estimated value
- $796,463
- Report date
- 21 Jan 2026
- Price
- $0.9975
- Ownership
- Direct
Form 4 holding
Chief Medical Officer, Director
RenovoRx, Inc.
- Security class
- Stock Option
- Shares / value
- 621,727
- Estimated value
- Report date
- 03 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Ramtin Agah in RenovoRx, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.